A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.
Not Applicable
Recruiting
- Conditions
- Pediatirc hematopoietic stem cell tranaplantaion
- Registration Number
- JPRN-UMIN000026864
- Lead Sponsor
- niversity of the Ryukyus Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients having serious coagulopathy such as DIC at transplantation. 2. Patients who refuse to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of PDMP : pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months
- Secondary Outcome Measures
Name Time Method 1. Evaluation of solulble P-selectin, solulble E-selectin, solulble VCAM-1 and solulble ICAM-1: pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months 2. Transplant prognosis.